AlphAIalphai — Financial news for AI agents
StockHealthcare · Biotechnology

$SPRY

ARS Pharmaceuticals, Inc.

Price · $SPRYvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $SPRY in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $SPRY in the last 30 days.

Top stories · $SPRYMore →
MAY 11·Foreign Policy JournalMed

Boeing [NYSE: BA] Commits $1.3 Billion to Wichita Site After Reacquiring Spirit AeroSystems

Boeing has announced a significant investment of $1.3 billion into its recently reacquired Wichita, Kansas facility over the next three years. This commitment follows Boeing's $8.3 billion reacquisition of Spirit AeroSystems in December 2025, aiming to centralize quality control and stabilize production after previous quality crises. The investment highlights Boeing's strategy to rebuild its manufacturing credibility and reinforce Wichita's role as a key aerospace hub.

APR 28·Stock Titan

BlackRock (SPRY) files amendment showing 4.98% ownership

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing beneficial ownership of 4,946,412 shares of ARS Pharmaceuticals, Inc. common stock, which represents 4.98% of the class. The filing indicates BlackRock holds sole voting power for 4,860,113 shares and sole dispositive power for all 4,946,412 shares. This amendment, signed by Spencer Fleming, Managing Director, on April 27, 2026, confirms that BlackRock's ownership is less than 5% and is held for passive investment purposes.

News on $SPRY

All news →